Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses
Nutrients · 29.10.2026 · 18 (21) · 3580
DOI: 10.3390/nu18213580 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Nutrients, online erschienen am 29.10.2026. Verfasst von Sara Santini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland. Hauptthemen laut MEDLINE: Prealbumin, Gastric Bypass, Absorptiometry, Photon, Body Composition. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Despite recognized physiological limitations, serum prealbumin continues to be measured during nutritional follow-up after bariatric surgery, and low concentrations may be interpreted as indicating inadequate lean-mass preservation. We aimed to evaluate the clinical utility of serum prealbumin for identifying disproportionate DXA-derived lean mass loss during the first three years after Roux-en-Y gastric bypass (RYGB) and to examine its association with DXA-derived lean-mass measurements at long-term follow-up.
Methods
In a longitudinal cohort of 178 adults, serum prealbumin and dual-energy X-ray absorptiometry (DXA)-derived body composition were assessed preoperatively, at 6 months, 1 year, and 3 years after surgery. Disproportionate lean mass loss was defined as lean mass accounting for >25% of total body weight lost. A complementary cross-sectional analysis examined associations between prealbumin and body composition in 310 participants assessed at a median of 8.8 years after RYGB.
Results
Prealbumin decreased from an estimated 0.260 g/L preoperatively to 0.203 g/L at 6 months and partially recovered thereafter, while absolute lean mass continued to decline through 3 years. Prealbumin showed poor discrimination of disproportionate lean mass loss, with AUCs of 0.36, 0.28, and 0.48 at 6 months, 1 year, and 3 years, respectively, although estimates were imprecise because of the small number of participants meeting the criterion. The
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland.
- Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 21, 1011 Lausanne, Switzerland.
- Interdisciplinary Center for Bone Disease, Lausanne University Hospital, 1011 Lausanne, Switzerland.
- NEXUS Personalized Health, ETH Zurich, 8092 Zurich, Switzerland.
- Department of Visceral Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland.
ORCID-Profile: Nathalie Vionnet, Elena Gonzalez-Rodriguez, Jérôme Pasquier, Styliani Mantziari, Lucie Favre
Zitieren
APA
Santini, S., Vionnet, N., Gonzalez-Rodriguez, E., Pasquier, J., Mantziari, S., & Favre, L. (2026). Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses. Nutrients, 18(21), 3580. https://doi.org/10.3390/nu18213580
Vancouver
Santini S, Vionnet N, Gonzalez-Rodriguez E, Pasquier J, Mantziari S, Favre L. Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses. Nutrients. 2026;18(21):3580. doi:10.3390/nu18213580
BibTeX
@article{Santini2026,
author = {Santini, Sara and Vionnet, Nathalie and Gonzalez-Rodriguez, Elena and Pasquier, Jérôme and Mantziari, Styliani and Favre, Lucie},
title = {Limited Clinical Utility of Serum Prealbumin for Assessing DXA-Derived Lean Mass After Roux-en-Y Gastric Bypass: Longitudinal and Long-Term Cross-Sectional Analyses},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {21},
pages = {3580},
doi = {10.3390/nu18213580}
}
EUVIMED